︎    ︎    ︎    

Gerard Evan, PhD, FMedSci, FRS, FAACR

Sir William Dunn Professor @Department of Biochemistry, University of Cambridge

Cambridge, United Kingdom

Gerard Evan received his BA in Biochemistry from the University of Oxford and his Ph.D. in Molecular Immunology from the MRC Laboratory of Molecular Biology at the University of Cambridge. He was then a Medical Research Council Post-Doctoral Fellow and, later, a Science and Engineering Research Council Fellow in the laboratory of J. Michael Bishop at the University of California, San Francisco (UCSF).

He then returned to the UK to become an Assistant Member of the Cambridge Branch of the Ludwig Institute for Cancer Research and a Research Fellow of Downing College, University of Cambridge. In 1988 he joined the Imperial Cancer Research Fund (ICRF) Laboratories in London as a Senior Scientist (1988-90) and then Principal Scientist from 1990-1999. In 1996 he was awarded the Royal Society’s Napier Professor of Cancer Research.

He was appointed to the Gerson and Barbara Bass Bakar Distinguished Professor of Cancer Biology at the University of California, San Francisco in 1999 and in 2009 moved to the UK to take up the Sir William Dunn chair of Biochemistry in the University of Cambridge.

Gerard is a member of EMBO, a Fellow of the UK Academy of Medical Sciences, the European Academy of Cancer Sciences, the Royal Society and the American Association for Cancer Research.
Visit the speaker’s lab here︎

This symposium is supported by QuantOCancer Project funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 810653.